OverviewChartNewsTraderScreen

UBS Knock-Out JNJ/  DE000UL8XFY4  /

UBS Investment Bank
2024-05-27  1:30:11 PM Chg.+0.050 Bid1:30:11 PM Ask1:30:11 PM Underlying Strike price Expiration date Option type
7.180EUR +0.70% 7.180
Bid Size: 2,500		 7.230
Ask Size: 2,500		 Johnson and Johnson 70.1249 USD 2078-12-31 Call
TeleTrader 05-01 J&J to pay $6.5 billion to settle US talc-related lawsuits
GlobeNewswire 04-17 TRC Amends Its Tender Offer for Johnson & Johnson
GlobeNewswire 04-10 SWAV Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Shockwave Medical t...
TeleTrader 04-05 J&J to acquire Shockwave Medical for $13.1B
TeleTrader 03-26 J&J may allegedly acquire Shockwave Medical
GlobeNewswire 03-15 CURE Media Group and Oncology Nursing News Announces the 2024 Extraordinary Healer® Award Finalists
GlobeNewswire 03-06 Ambrx Shareholders Approve Acquisition by Johnson & Johnson
TeleTrader 01-27 J&J, Merck CEOs to testify before Senate on drug prices
TeleTrader 01-24 J&J to pay $149.5M to settle Washington state opioid case
TeleTrader 01-23 J&J to pay $700M in talc powder probe settlement
TeleTrader 01-23 J&J's Q4 sales top estimates, up 7.3% to $21.4B
TeleTrader 01-23 Johnson & Johnson Q4 earnings preview
TeleTrader 01-22 Earnings preview: Tesla takes center stage
TeleTrader 01-08 J&J to buy biotech company Ambrx for $2B
GlobeNewswire 2023-12-04 Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovat...
GlobeNewswire 2023-12-04 Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovat...
TeleTrader 2023-11-07 J&J to begin trials with surgical robot
TeleTrader 2023-10-17 J&J's Q3 sales up 6.8% to $21.4 billion
TeleTrader 2023-10-03 J&J's $223.8M talc powder case fine overturned
TeleTrader 2023-08-29 US gov't reveals drugs subject to Medicare price debate
TeleTrader 2023-07-20 J&J highest since January as Q2 results top estimates
TeleTrader 2023-07-20 J&J's Q2 sales rise by 6.3% to $25.5 billion
TeleTrader 2023-07-18 J&J joins drug price suits against US gov't
TeleTrader 2023-05-04 J&J's Kenvue reportedly valued at $41B for IPO
TeleTrader 2023-04-24 J&J reportedly hopes to raise $3.5B in Kenvue roadshow